Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Huicheng Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and production of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and finished dosage forms. The company operates as an integrated service provider, offering contract research (CRO) and contract manufacturing (CMO) services alongside its proprietary product development. Its portfolio primarily focuses on small molecule therapeutics across various therapeutic areas, including cardiovascular health, metabolic diseases, and anti-infectives. Nanjing Huicheng Pharmaceutical maintains high-standard manufacturing facilities and provides technical support for drug registration and technology transfer to global partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Huicheng Pharmaceutical.